Liver transplantation overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{CMG}}; {{AE}} {{MAD}} {{Liver transplantation}} ==Overview== ==Liver transplantation indications== Indications for liver transplantation include acute liver fail..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{MAD}} | {{CMG}}; {{AE}} {{MAD}} | ||
{{Liver transplantation}} | {{Liver transplantation}} | ||
| Line 6: | Line 7: | ||
==Liver transplantation indications== | ==Liver transplantation indications== | ||
Indications for liver transplantation | Indications for liver transplantation include [[acute liver failure]], [[Cirrhosis|cirrhosis,]] [[Liver neoplasms]], and metabolic disorders such as [[Familial amyloid polyneuropathy]], [[Primary hyperoxaluria]], [[Cystic fibrosis]], [[Alpha 1-antitrypsin deficiency|alpha-1 antitrypsin deficiency]], [[glycogen storage disease]], t[[Tyrosinemia|yrosinemia]], h[[Hemochromatosis|emochromatosis]], [[Wilson's disease|Wilson disease]], and [[Acute intermittent porphyria]]. | ||
Revision as of 21:03, 18 December 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
|
Liver trasnsplantation Microchapters |
Overview
Liver transplantation indications
Indications for liver transplantation include acute liver failure, cirrhosis, Liver neoplasms, and metabolic disorders such as Familial amyloid polyneuropathy, Primary hyperoxaluria, Cystic fibrosis, alpha-1 antitrypsin deficiency, glycogen storage disease, tyrosinemia, hemochromatosis, Wilson disease, and Acute intermittent porphyria.